Modulation of cisplatin cytotoxicity and cisplatin-induced DNA cross-links in HepG2 cells by regulation of glutathionerelated mechanisms

Molecular Pharmacology

Volumn 59, Issue 4, 2001, Pages 837-843

  Zhang, Kai ^a   Chew, May ^a   Yang, Er Bin ^a   Wong, Kim Ping ^b   Mack, Peter ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETACRYNIC ACID; GLUTATHIONE; INDOMETACIN;

ARTICLE; CYTOTOXICITY; DETOXIFICATION; DNA CROSS LINKING; DRUG DNA INTERACTION; DRUG EFFECT; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

EID: 0035057452     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.4.837     Document Type: Article

References (42)

1. Buthionine sulfoximine induction of γ-L-Glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA cross-link and cytotoxicity in human glioma cells
2. Modulation of cisplatin cytotoxicity by sulphasalazine
3. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma
4. A rapid and sensitive method for quantification of microgram quantities of protein utilising the principle of protein-dye binding
5. Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates
6. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein. MRP2, permanently expressed in human and canine cells
7. Detection of DNA cross-links in tumor cells with the ethidium bromide fluorescence assay
8. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP but not P-glycoprotein
9. Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs)
10. Review of the comparative pharmacology and clinical activity of cisplatin and carhoplatin
11. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis
12. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells
13. Overexpression of multidrug resistance-associated protein (MRP) increase resistance to natural product drugs
14. Mechanisms of action, metabolism and toxicity of buthionine sulphoximine and its high homologs, potent inhibitor of glutathione synthesis
15. Glutathione S-transferases: The first enzyme step in mercapturic acid formation
16. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill
17. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione S-transferase inhibitor ethacrynic acid
18. Increased cisplatin sensitivity of human fibroblasts from a subject with inherent glutathione deficiency
19. Co-expression of gamma-glutamylcysteine synthetase sub-units in response to cisplatin and doxorubicin in human cancer cells
20. The ATP-dependent glutathione S-conjugate export pump
21. Glutathione-associated cis-diamminedichloro-platinum (II) metabolism and ATP-dependent efflux from leukemia cells, molecular characterization of glutathione-platinum complex and its biological significance
22. GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum (II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation
23. Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance
24. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines
25. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma
26. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds
27. Combined expression of multidrug resistance protein (MRP) and glutathione S-transferase P1-1 (GSTP1-1) in MCF cells and high level resistance to the cytotoxicities of ethacrynic acid but not oxazaphosphorine or cisplatin
28. Glutathione conjugate transport by human colon adenocarcinoma cells
29. Cellular and molecular determinants of cisplatin resistance
30. Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation
31. Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines
32. Glutathione-associated enzymes in anticancer drug resistance
33. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines
34. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein
35. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein
36. Inhibitory effects of plant polyphenols on rat liver glutathione S-transferases
37. Glutathione-related mechanisms in cellular resistance to anticancer drugs
38. Inhibition of the efflux of glutathione S-conjugate by plant polyphenols
39. Glutathione conjugation of chlorambucil: Measurement and modulation by plant polyphenols
40. Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin
41. Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines